Type 1 diabetes is widely believed to be an autoimmune disorder, in which the body mistakenly attacks the pancreas’ own insulin-producing beta cells. If this is the case, immunotherapy could potentially be used to treat it, yet few trials to date have examined its potential. A new trial from researchers in the UK has investigated the safety and effectiveness of immunotherapy, and the treatment seems to offer promise. Read more